InvestorsHub Logo
Followers 132
Posts 8090
Boards Moderated 1
Alias Born 01/31/2017

Re: None

Tuesday, 07/31/2018 12:06:00 PM

Tuesday, July 31, 2018 12:06:00 PM

Post# of 192
Just a year ago, the FDA gave its first drug candidate Orphan Drug Status, basically a ticket for the fast lane through FDA approval. At the time, trials for the drug were set to begin in 2018 and PhaseRX had a market value of $61 million.